⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 23, 2024Asian journal of urologyOpen Access

Prediction of recurrence risk in patients with non-muscle invasive bladder cancer

Niloufar Ahmadi Hamid Shafee Emadoddin Moudi

View Full Paper

Ask AI

Bookmark

Share

Abstract

Non-muscle-invasive bladder cancer (NMIBC) remains a common challenge in uro-oncology with conflicting reports on recurrence risk. This study aimed to elucidate the recurrence rate of NMIBC in the Cancer Clinic of Shahid Beheshti Hospital in Iran and to investigate related parameters affecting recurrence risk.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ahmadi et al. (2024) studied this question.

synapsesocial.com/papers/68e77e09b6db6435876f24d2 https://doi.org/10.1016/j.ajur.2023.04.007

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical, Morphological and Immunohistochemical Criteria for Predicting Recurrence of Non-Muscle Invasive Bladder CancerOriginal Research · 2026
2Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancerPrognostic Study · 2026
3Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters2024 · 4 citations
4Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancerOriginal Research · 2026 · 1 citations
5Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear featuresOriginal Research · 2021 · 59 citations

More related papers

Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials.2026
Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle‐invasive bladder cancer in a multisite, community‐based cohort2020
Clinical significance of tumor location in non-muscle-invasive bladder cancer: A single-center longitudinal cohort analysis2025

More from Asian journal of urology

Cytoreductive treatment for oligometastatic prostate cancer: Current status and future prospectsThu,
Initial clinical validation of the “wrist-like” robotic system (EDGE SP1000 Plus) in extraperitoneal single-port robot-assisted radical prostatectomyTue,